Chesapeake Wealth Management Eli Lilly & CO Transaction History

Chesapeake Wealth Management

$291 Million
Q3 2024

A detailed history of Chesapeake Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Chesapeake Wealth Management holds 3,430 shares of LLY stock, worth $2.57 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

3,430

Previous 3,537 3.03%

Holding current value

$2.57 Million

Previous $3.2 Million 5.12%

% of portfolio

1.04%

Previous 1.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $82,618 - $102,722	-107 Reduced 3.03%	3,430 $3.04 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $97,857 - $122,720	-135 Reduced 3.68%	3,537 $3.2 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $301,429 - $403,270	-509 Reduced 12.17%	3,672 $2.86 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $123,944 - $146,114	-236 Reduced 5.34%	4,181 $2.44 Million
Q3 2023 Nov 16, 2023	SELL	$434.7 - $599.3 $123,020 - $169,601	-283 Reduced 6.02%	4,417 $2.37 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $20,693 - $27,669	-59 Reduced 1.24%	4,700 $2.2 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $24,539 - $28,820	-79 Reduced 1.63%	4,759 $1.63 Million
Q4 2022 Feb 23, 2023	SELL	$321.55 - $374.67 $63,666 - $74,184	-198 Reduced 3.93%	4,838 $1.77 Million
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $76,491 - $87,170	-258 Reduced 4.87%	5,036 $1.63 Million
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $18,396 - $21,599	-66 Reduced 1.23%	5,294 $1.72 Million
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $78,151 - $97,122	-333 Reduced 5.85%	5,360 $1.54 Million
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $40,473 - $50,227	-180 Reduced 3.06%	5,693 $1.57 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $151,796 - $186,806	-685 Reduced 10.45%	5,873 $1.36 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $134,148 - $173,520	-743 Reduced 10.18%	6,558 $1.51 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $63,263 - $81,897	-385 Reduced 5.01%	7,301 $1.36 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $42,921 - $56,795	-329 Reduced 4.1%	7,686 $1.3 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $731 - $845	-5 Reduced 0.06%	8,015 $1.19 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $7,912 - $9,522	58 Added 0.73%	8,020 $1.32 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $2,023 - $2,504	-17 Reduced 0.21%	7,962 $1.1 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $231,374 - $286,578	-2,164 Reduced 21.33%	7,979 $1.05 Million
Q3 2019 Oct 25, 2019	SELL	$106.79 - $116.16 $695,416 - $756,433	-6,512 Reduced 39.1%	10,143 $1.13 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $214,378 - $250,234	1,935 Added 13.15%	16,655 $1.85 Million
Q1 2019 Apr 17, 2019	BUY	$111.31 - $131.02 $366,989 - $431,972	3,297 Added 28.86%	14,720 $1.91 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $265,809 - $297,786	2,510 Added 28.16%	11,423 $1.32 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $12,793 - $15,989	-149 Reduced 1.64%	8,913 $957,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $28,841 - $33,101	-381 Reduced 4.03%	9,062 $774,000
Q1 2018 Jun 04, 2018	BUY	$74.21 - $87.6 $700,765 - $827,206	9,443 New	9,443 $730,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.

Account

Chesapeake Wealth Management Eli Lilly & CO Transaction History